North America DNA Sequencing Products Market Grow at CAGR of 15.4% during 2022-2027

According to the latest report by IMARC Group, titled "North America DNA Sequencing Products Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the North America DNA sequencing products market reached a value of US$ 2.2 Billion in 2021. The market is anticipated to reach a value of US$ 5.2 Billion by 2027, exhibiting a CAGR of 15.4% during 2022-2027.

Get Free Sample Copy of Report at - https://www.imarcgroup.com/north-america-dna-sequencing-products-market/requestsample

DNA sequencing refers to the process of understanding the accurate sequence of the four nucleotide bases, namely guanine, thymine, adenine and cytosine, present within a DNA molecule. It is widely used for mapping out the human genome and for various applied research applications. It is crucial in determining multiple nucleotide variations related to distinctive genetic diseases, thereby aiding in the study of several complex disorders. Apart from this, it is extensively used for numerous research studies and applications, such as genome editing, forensic sciences, agrigenomics, species discovery, DNA recombination, hereditary disease detection, and phylogenetic analysis.

North America DNA Sequencing Products Market Growth Drivers:

The North American market is primarily driven by the growing utilization of DNA sequencing products in in-vitro diagnostics. These diagnostics are used to detect multiple diseases and monitor a person's overall health for curing and preventing several medical conditions. Since next-generation sequencing tests are usually performed to scan a person's DNA for detecting genomic variations, this is providing a thrust to the market growth. The growing preference for personalized medicines and targeted therapies among patients is acting as a major growth-inducing factor. DNA sequencing provides information about the genetic basis of several diseases. This aids in the development of precise treatments to affect the pathogens in the body without damaging healthy cells.

The market is further driven by the increasing initiatives undertaken by several industry players in the region to facilitate the development of new and affordable technologies. For instance, the National Human Genome Research Institute (NHGRI), a US-based institute and a part of the National Institutes of Health (NIH), offers grants in developing cost-effective DNA sequencing with the use of nanoscale technologies. Numerous companies are also engaging to develop alternative sequencing technologies that offer improved yield, speed and sensitivity, thereby creating a positive outlook for the market.

Do you know more information, Contact to our analyst at- https://www.imarcgroup.com/north-america-dna-sequencing-products-market

Key Market Segmentation:

Key Regions Analysed:

• United States
• Canada
• Analysis for Each Country

Market by Product Type:

• Consumables and Reagents
• Equipments

Market by Application:

• Biomarkers
• Diagnostics
• Reproductive Health
• Forensics
• Personalized Medicine
• Others

Market by End-User:

• Academic and Government Research Institutes
• Pharmaceutical and Biotechnology Companies
• Hospitals and Clinics
• Others

• Value Chain Analysis
• Key Drivers and Challenges
• Porters Five Forces Analysis
• Competitive Landscape

Browse More Research Reports:

• https://www.imarcgroup.com/heparin-market
• https://www.imarcgroup.com/intelligent-transport-systems-market
• https://www.imarcgroup.com/ion-exchange-resins-market
• https://www.imarcgroup.com/chemical-sensors-market
• https://www.imarcgroup.com/shape-memory-alloys-market

Contact us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Who we are:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.